Paloma Partners Management CO Alkermes Plc. Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $2.91 Million - $4.74 Million	-222,936 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $2.14 Million - $2.69 Million	123,917 Added 125.14%	222,936 $4.55 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $1.93 Million - $2.4 Million	99,019 New	99,019 $1.93 Million
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $197,926 - $316,017	-7,084 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $273,442 - $326,714	7,084 New	7,084 $301,000
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $395,802 - $496,580	-7,383 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $123,564 - $143,515	2,591 Added 54.07%	7,383 $405,000
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $235,574 - $260,924	4,792	4,792 $244,000

360

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.